| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/17/2014 | US20140199299 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists |
| 07/17/2014 | US20140199298 Combination treatment of cancer comprising egfr/her2 inhibitors |
| 07/17/2014 | US20140199297 Triterpene glycoside and triterpene compositions and methods of using same |
| 07/17/2014 | US20140199296 Cancer Drug and Uses |
| 07/17/2014 | US20140199292 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence |
| 07/17/2014 | US20140199291 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) |
| 07/17/2014 | US20140199238 Targeting of Bone Marrow Neovasculature |
| 07/17/2014 | US20140199236 Androgen receptor modulator and uses thereof |
| 07/17/2014 | US20140199232 Targeted Therapeutic Nanoparticles |
| 07/16/2014 | EP2754713A1 ANTIBODY AGAINST MUTANT alpha-ACTININ-4 |
| 07/16/2014 | EP2754671A2 Anti MIF antibodies |
| 07/16/2014 | EP2754452A1 SigC for modulation of immune responses |
| 07/16/2014 | EP2754436A1 Biodegradable high-efficiency dengue vaccine, method for making the same, and pharmaceutical composition comprising the same |
| 07/16/2014 | EP2754435A1 Biodegradable carrier with adjustable zeta potentials and particle sizes, method for making the same, and pharmaceutical composition comprising the same |
| 07/16/2014 | EP2753686A2 Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same |
| 07/16/2014 | EP2753646A1 Anti-cd40 antibodies, uses and methods |
| 07/16/2014 | EP2753358A2 Fungal-specific metalloproteases and uses thereof |
| 07/16/2014 | EP2753357A1 Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients |
| 07/16/2014 | EP2753356A1 Anti-siglec-15 antibodies and uses thereof |
| 07/16/2014 | EP2753355A2 Oncolytic herpes simplex virus and therapeutic uses thereof |
| 07/16/2014 | EP2753354A1 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine |
| 07/16/2014 | EP2753353A1 Bioconjugate vaccines made in prokaryotic cells |
| 07/16/2014 | EP2753352A1 Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof |
| 07/16/2014 | EP2753351A1 Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment |
| 07/16/2014 | EP2753349A1 Submicron particles to decrease transfusion |
| 07/16/2014 | EP2753348A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate |
| 07/16/2014 | EP2753337A1 Compositions including beta-glucans and methods of use |
| 07/16/2014 | CN1638800B 抗cd30的人类单克隆抗体 The human monoclonal antibody anti-cd30 |
| 07/16/2014 | CN103930443A 通过拮抗il-6受体抑制肿瘤生长的方法 Il-6 receptor by antagonizing the inhibition of tumor growth method |
| 07/16/2014 | CN103930442A 抗cd40抗体、用途和方法 Anti-cd40 antibodies, and methods of use |
| 07/16/2014 | CN103930436A 大肠杆菌疫苗组合 E. coli vaccine combination |
| 07/16/2014 | CN103930435A 增加植物中病毒样颗粒的产率 Increase the yield of a plant virus-like particles |
| 07/16/2014 | CN103930131A 用于针对耐药性鲍氏不动杆菌的免疫的组合物和方法 The compositions and methods for immunization against resistant Acinetobacter spp for |
| 07/16/2014 | CN103930130A 抗第三方中央型记忆t细胞、其产生方法以及其在移植和疾病治疗中的应用 T anti-third party central memory cells, which produce methods and their use in transplantation and in the treatment of disease |
| 07/16/2014 | CN103930122A 用于检测、预防和治疗白斑病的mia（黑素瘤抑制性活性蛋白）抑制剂 Mia for the detection, prevention and treatment of vitiligo (melanoma inhibitory activity protein) inhibitor |
| 07/16/2014 | CN103930111A 包含c-met拮抗剂和b-raf拮抗剂的组合治疗 Contains the c-met antagonist and b-raf antagonist combination therapy |
| 07/16/2014 | CN103923943A 一种基于腺病毒AdC7的表达载体及其构建方法 An adenovirus vector based on its construction method AdC7 |
| 07/16/2014 | CN103923886A 流感病毒温度敏感株关键位点的筛选、突变株及其机制的探讨 Discussion screening temperature-sensitive strains of influenza virus key sites, mutant and its mechanism |
| 07/16/2014 | CN103923885A 鸡传染性法氏囊病毒Vero细胞适应株及其应用 IBD virus strain Vero cell adaptation and its application |
| 07/16/2014 | CN103923884A 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 Pig gene deletion strain of pseudorabies virus vaccine composition and preparation method and application |
| 07/16/2014 | CN103923882A 甲肝病毒单克隆抗体及其应用 Hepatitis A virus monoclonal antibodies and their application |
| 07/16/2014 | CN103923881A 甲肝病毒单克隆抗体及其应用 Hepatitis A virus monoclonal antibodies and their application |
| 07/16/2014 | CN103923214A 抗肝癌干细胞单克隆抗体及其应用 Monoclonal antibodies against hepatocellular carcinoma stem cells and its application |
| 07/16/2014 | CN103923213A 结合淋巴细胞活化基因3(lag-3)之人类抗体及其用途 Combined lymphocyte activation gene 3 (lag-3) of human antibodies and their use |
| 07/16/2014 | CN103923165A 从杨树菇中分离的具有免疫佐剂作用的蛋白提取物及其提取方法和应用 Separated from the protein extract from Agrocybe immune adjuvant effect of its extraction methods and applications |
| 07/16/2014 | CN103920150A Satb1在治疗皮肤t细胞淋巴瘤中的应用 Satb1 used in the treatment of cutaneous t-cell lymphoma |
| 07/16/2014 | CN103920148A 一种单克隆抗体制剂的冷冻干燥工艺 A monoclonal antibody formulation freeze drying process |
| 07/16/2014 | CN103920147A 一种美洲大蠊过敏原制剂的制备方法 An American cockroach allergy preparation of the original formulation |
| 07/16/2014 | CN103920146A 猪圆环病毒Ⅱ型与猪伪狂犬病二联疫苗及其制备方法和应用 Porcine circovirus type Ⅱ porcine pseudorabies bivalent vaccine and its preparation method and application |
| 07/16/2014 | CN103920145A 一种肿瘤细胞疫苗及其制备方法 A tumor cell vaccine and its preparation method |
| 07/16/2014 | CN103920142A 治疗和诊断年龄相关性黄斑变性的方法和试剂 Treatment and diagnosis of age-related macular degeneration methods and reagents |
| 07/16/2014 | CN103920139A 活化素-actriia拮抗剂及在治疗或预防乳腺癌中的用途 Activin -actriia antagonists and use in the treatment or prevention of breast cancer |
| 07/16/2014 | CN103919889A 一种增强大菱鲆免疫力的中药组合物 An enhanced immunity turbot Chinese medicinal composition |
| 07/16/2014 | CN103919804A 治疗消化功能紊乱的组合物和方法 Treatment of digestive disorders compositions and methods |
| 07/16/2014 | CN103087996B 重组猪繁殖与呼吸综合征病毒及其制备方法与应用 Virus and its preparation method and application of recombinant porcine reproductive and respiratory syndrome |
| 07/16/2014 | CN103087173B 基于TGF-β1的B细胞抗原表位的合成肽疫苗及其应用 TGF-β1 on the B cell epitope of a synthetic peptide vaccine and Applications |
| 07/16/2014 | CN103013895B 猪流行性腹泻病毒重组猪霍乱沙门氏菌基因工程活疫苗及制备与应用 Porcine epidemic diarrhea virus genetically engineered recombinant Salmonella choleraesuis vaccine and preparation and application |
| 07/16/2014 | CN103012589B 人源抗人血管内皮细胞生长因子抗体及其应用 Human anti-human vascular endothelial growth factor antibody and its application |
| 07/16/2014 | CN102753577B 双特异性抗-vegf/抗-ang-2抗体 Bispecific anti -vegf / anti -ang-2 antibody |
| 07/16/2014 | CN102711812B Tau蛋白病治疗用疫苗 Tau protein disease therapeutic vaccine |
| 07/16/2014 | CN102657857B 一种利用沙鼠肾细胞制备肠道病毒疫苗的方法 An intestinal virus vaccines prepared using gerbils renal cell method |
| 07/16/2014 | CN102370981B 防治神经退行性疾病的试剂和方法 Reagents and methods of prevention and treatment of neurodegenerative diseases |
| 07/16/2014 | CN102369218B 抗-FcRH5抗体和免疫缀合物以及应用方法 Antibodies and anti--FcRH5 immunoconjugates and application methods |
| 07/16/2014 | CN102264388B 含有特异性识别cd38的抗体和长春新碱的抗肿瘤组合 Antitumor composition comprising an antibody that specifically recognize cd38 and vincristine |
| 07/16/2014 | CN102186502B 免疫学组合物 Immunological composition |
| 07/16/2014 | CN102015766B 用于对巨细胞病毒感染进行治疗以及诊断的组合物以及方法 For the treatment of cytomegalovirus infection and diagnostic compositions and methods |
| 07/16/2014 | CN101983069B 流感血凝素和神经氨酸酶变体 Influenza hemagglutinin and neuraminidase variants |
| 07/16/2014 | CN101903402B 抗tl1a的人源化抗体 Anti tl1a of humanized antibody |
| 07/16/2014 | CN101849001B 修饰抗体的方法和具有改善的功能性质的修饰抗体 Modified antibodies having improved functional properties of the modified antibody |
| 07/16/2014 | CN101809148B 神经元和脑肿瘤的新型免疫疗法 Neurons and brain tumors novel immunotherapy |
| 07/16/2014 | CN101522217B 抗原剂量降低的加强免疫疫苗的制造 Antigen dose reduction to strengthen the manufacture of vaccines |
| 07/15/2014 | USRE45016 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 07/15/2014 | US8779108 Targeted binding agents against B7-H1 |
| 07/15/2014 | US8779107 Composition for targeting dendritic cells |
| 07/15/2014 | US8779105 Monoclonal antibodies to programmed death 1 (PD-1) |
| 07/15/2014 | US8779104 EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof |
| 07/15/2014 | US8779103 Drug fusions and conjugates |
| 07/15/2014 | US8779101 IL-17 binding proteins |
| 07/15/2014 | US8779100 Humanized anti-beta7 antagonists and uses therefor |
| 07/15/2014 | US8779099 MIF antagonists |
| 07/15/2014 | US8779098 B7-H3L cell surface antigen and antibodies that bind thereto |
| 07/15/2014 | US8779088 Vaccine for the treatment of Mycobacterium related disorders |
| 07/15/2014 | US8778962 Treatment of solid tumors with rapamycin derivatives |
| 07/15/2014 | US8778961 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/15/2014 | US8778886 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| 07/15/2014 | US8778885 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 07/15/2014 | US8778671 Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus |
| 07/15/2014 | US8778655 Modified gram-negative bacteria for use as vaccines |
| 07/15/2014 | US8778653 Method for reducing DNA impurities in viral compositions |
| 07/15/2014 | US8778634 Non-cytotoxic protein conjugates |
| 07/15/2014 | US8778615 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 07/15/2014 | US8778384 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
| 07/15/2014 | US8778361 Canine tumor cell and allogeneic dendritic cell fused vaccine and method for preparing the same |
| 07/15/2014 | US8778359 Stable anthrax vaccine formulations |
| 07/15/2014 | US8778358 Immunogenic compositions for gram positive bacteria such as Streptococcus agalactiae |
| 07/15/2014 | US8778356 Vaccine |
| 07/15/2014 | US8778355 Infectious bovine viral diarrhea virus |
| 07/15/2014 | US8778354 Compositions and methods for modulating RSV infection and immunity |
| 07/15/2014 | US8778353 Influenza virus-like particle (VLP) compositions |
| 07/15/2014 | US8778352 Polyvalent chimeric OspC vaccinogen and diagnostic antigen |